½ÃÀ庸°í¼­
»óǰÄÚµå
1599347

ÀΰøÈĵΠ±â±â ½ÃÀå : ¹ëºê, ±â±â, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Voice Prosthesis Device Market by Valve (Blom-Singer Valve, Groningen Valve, Provox Valve), Device (Indwelling Voice Prosthesis Devices, Non-Dwelling Voice Prosthesis Devices), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀΰøÈĵΠ±â±â ½ÃÀåÀº 2023³â 1¾ï 7,649¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 1¾ï 8,929¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 7.35%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 2¾ï 8,999¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀΰøÈĵΠ±â±â ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ¿¡´Â ¾Ï Ä¡·á¿¡¼­ ÈçÈ÷ ÇÊ¿äÇÑ ÈĵΠÀýÁ¦¼ú ÈÄ ¾ð¾î ´É·Â ȸº¹À» µ½±â À§ÇØ °í¾ÈµÈ Á¦Ç°µéÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀåÄ¡´Â ÀÚ¿¬½º·¯¿î ¸ñ¼Ò¸®¸¦ ÀÒÀº »ç¶÷µéÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ½É¸®Àû, »ý¸®Àû Ãø¸é¿¡¼­ Å« ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÁÖ·Î ÀÇ·á ½Ã½ºÅÛ, ƯÈ÷ º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC) ¹× Àü¹® Ŭ¸®´Ð¿¡¼­ »ç¿ëµË´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§´Â ÁÖ·Î ÈĵΠ¼ö¼úÀ» ¹Þ°í ¹ß¼º ÀçȰÀ» ÇÊ¿ä·Î Çϴ ȯÀÚµéÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â µÎ°æºÎ¾Ï Áõ°¡, ¾ð¾î ÀçȰ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¦Ç°ÀÇ È¿´ÉÀ» Çâ»ó½ÃŰ´Â ÀÇ·á ±â¼úÀÇ ¹ßÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 1¾ï 7,649¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 1¾ï 8,929¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 2¾ï 8,999¸¸ ´Þ·¯
CAGR(%) 7.35%

ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í ÷´Ü ÇコÄÉ¾î ¼Ö·ç¼Ç µµÀÔÀÌ È°¹ßÈ÷ ÀÌ·ïÁö°í ÀÖ´Â ½ÅÈï ½ÃÀå¿¡ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ±â±âÀÇ Æí¾ÈÇÔ°ú ¼ö¸íÀ» Çâ»ó½ÃŰ´Â ¼ÒÀç ¹× µðÀÚÀÎ Çõ½ÅÀº °æÀï ¿ìÀ§¸¦ È®º¸ÇÒ ¼ö ÀÖ´Â ÀáÀçÀû °æÀï ¿ìÀ§¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. ¿øÈ°ÇÑ È¯ÀÚ ÀÇ·Ú °æ·Î¸¦ À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Êµµ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ±â±âÀÇ ³ôÀº ºñ¿ë, ƯÁ¤ Áö¿ªÀÇ Á¦ÇÑµÈ »óȯ ½Ã³ª¸®¿À, ÀÎ½Ä ºÎÁ· ¹× ÀÎ½Ä À庮À¸·Î ÀÎÇÑ º¸Ã¶ ¼Ö·ç¼Ç äÅÿ¡ ´ëÇÑ È¯ÀÚÀÇ °ÅºÎ°¨ µîÀÇ °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â±âÀÇ Á¤±âÀûÀÎ »çÈİü¸®¿Í À¯Áöº¸¼ö°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­´Â ÇѰ谡 ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº º¸´Ù Àú·ÅÇϰí À¯Áöº¸¼ö°¡ ¿ëÀÌÇÏ¸ç »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â±â °³¹ß¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÕº´ÁõÀ» ÁÙÀ̰í ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ¿ì¼öÇÑ »ýüÀûÇÕ¼º Àç·á¿¡ ´ëÇÑ ¿¬±¸ÀÇ ¿©Áö°¡ ÀÖ½À´Ï´Ù. ÀÇ·á ¿¬±¸ ±â°ü°ú Çù·ÂÇÏ¿© ½Åü Á¶Á÷°úÀÇ ±â±â ÅëÇÕÀ» °³¼±ÇÏ´Â ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃßÁøÇϸé Á¦Ç° ¶óÀÎÀ» °­È­ÇÒ ¼ö ÀÖ´Â ±æÀÌ ¿­¸± °ÍÀÔ´Ï´Ù. ½ÃÀå °æÀïÀº ±â¼ú ÁÖµµÇüÀ̱⠶§¹®¿¡ ±â¾÷Àº Áö¼ÓÀûÀÎ Á¦Ç° ¹ßÀü°ú źźÇÑ À¯Åë¸ÁÀ¸·Î ¾Õ¼­ ³ª°¡¾ß¸¸ ÁøÈ­ÇÏ´Â °æÁ¦±Ç¿¡¼­ Å« ½ÃÀå Á¡À¯À²À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀΰøÈĵΠ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

º¸Ã»±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Èĵξϰú ÀεξÏÀÇ Àü ¼¼°è ¹ßº´·ü »ó½Â
    • Ä¡·á ±â±â¿¡ ´ëÇÑ È¯ÀÚÀÇ ÀÎ½Ä Á¦°í
    • À¯¸®ÇÑ »óȯ Á¤Ã¥À» ÀÌ¿ëÇÒ ¼ö ÀÖ°í, ´ë»ó ȯÀÚ Àα¸°¡ ¸¹¾Æ¾ß ÇÕ´Ï´Ù.
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Á¶ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ »ó´ëÀûÀ¸·Î °í°¡ÀÇ ±â±âÀÓ.
  • ½ÃÀå ±âȸ
    • º¸°ÇÀÇ·á¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áö¿ø Áõ°¡
    • ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í ¸»Çϱ⠳ë·ÂÀ» ÁÙÀ̱â À§ÇØ ÀåÄ¡¸¦ ¸ÂÃãÈ­Çϱâ À§ÇÑ ±¤¹üÀ§ÇÑ Á¶»ç ¹× °³¹ß
  • ½ÃÀå °úÁ¦
    • ±â±â »ç¿ë ½Ã ÇÕº´Áõ ¹ß»ý ¹× ªÀº ¼ö¸í

Porter's Five Forces : ÀΰøÈĵΠ±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ÀΰøÈĵΠ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀΰøÈĵΠ±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀΰøÈĵΠ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀΰøÈĵΠ±â±â ½ÃÀå °æÀï »óȲ ÆÄ¾Ç

ÀΰøÈĵΠ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀΰøÈĵΠ±â±â ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀΰøÈĵΠ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÀΰøÈĵΠ±â±â ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸³´Ï´Ù.

¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÀΰøÈĵΠ±â±â ½ÃÀå Àü·« ºÐ¼®Àº ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀΰøÈĵΠ±â±â ½ÃÀå : ¹ëºêº°

  • ºí·Ò-½Ì¾î ¹ëºê
  • Èå·Î´×¾ð ¹ëºê
  • ÇÁ·Îº¹½º ¹ëºê

Á¦7Àå ÀΰøÈĵΠ±â±â ½ÃÀå : ±â±âº°

  • À¯Ä¡Çü ÀΰøÈĵΠ±â±â
  • ºñÀ¯Ä¡Çü ÀΰøÈĵΠ±â±â

Á¦8Àå ÀΰøÈĵΠ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀΰøÈĵΠ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀΰøÈĵΠ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀΰøÈĵΠ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Andreas Fahl Medizintechnik-Vertrieb GmbH
  • Coloplast A/S
  • Demant A/S
  • E. Benson Hood Laboratories, Inc.
  • Griffin Laboratories, Inc.
  • InHealth Technologies
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Luminaud Inc.
  • Nu-Vois
  • Orbisana Healthcare
  • Smiths Group PLC
  • Sonova Holding AG
  • Teleflex Incorporated
  • Ultravoice Limited
ksm 24.12.04

The Voice Prosthesis Device Market was valued at USD 176.49 million in 2023, expected to reach USD 189.29 million in 2024, and is projected to grow at a CAGR of 7.35%, to USD 289.99 million by 2030.

The scope and definition of the voice prosthesis device market involve products designed to help individuals regain speech ability after a laryngectomy, which is often necessitated by cancer treatments. These devices are crucial in improving the quality of life for individuals who have lost their natural voice, providing a significant psychological and physiological benefit. They find application primarily in the healthcare system, particularly in hospitals, ambulatory surgical centers, and specialized clinics. The end-use scope primarily includes patients who have undergone laryngeal surgeries and require assistance with speech rehabilitation. Market insights suggest key growth factors include a rise in head and neck cancer incidences, increasing awareness about speech rehabilitation solutions, and advancements in medical technology enhancing product efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 176.49 million
Estimated Year [2024] USD 189.29 million
Forecast Year [2030] USD 289.99 million
CAGR (%) 7.35%

Opportunities lie in emerging markets that have a growing healthcare infrastructure and increasing adoption of advanced healthcare solutions. Innovating in materials and designs that improve device comfort and longevity holds potential for competitive advantage. Strategic partnerships with healthcare providers for seamless patient referral pathways could be beneficial. However, challenges such as high costs of these devices, limited reimbursement scenarios in certain regions, and patient reluctance towards adopting prosthetic solutions due to lack of awareness or perception barriers may hamper market growth. Additionally, the need for regular follow-up and maintenance of devices poses limitations in resource-constrained settings.

Innovation can focus on developing more affordable, easy-to-maintain, and user-friendly devices. There is scope in research for superior biocompatible materials that reduce complications and enhance patient comfort. Collaborating with medical research institutions to drive forward initiatives in improving device integration with body tissues could also pave a way for enhanced product lines. The nature of the market is competitive and technology-driven, requiring companies to stay ahead with continuous product advancements and robust distribution networks to capture significant market share in evolving economies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Voice Prosthesis Device Market

The Voice Prosthesis Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of laryngeal and throat cancer globally
    • Increasing patient awareness on the availability of these devices for treatment
    • Availability of favorable reimbursement policies and presence of large target patient population
  • Market Restraints
    • Relatively expensive device due to high cost of manufacturing
  • Market Opportunities
    • Increasing government funding on healthcare
    • Extensive research and development to customize the device to improve patient compliance and reduced effort to speak
  • Market Challenges
    • Associated complications on the device usage and short lifespan

Porter's Five Forces: A Strategic Tool for Navigating the Voice Prosthesis Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Voice Prosthesis Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Voice Prosthesis Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Voice Prosthesis Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Voice Prosthesis Device Market

A detailed market share analysis in the Voice Prosthesis Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Voice Prosthesis Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Voice Prosthesis Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Voice Prosthesis Device Market

A strategic analysis of the Voice Prosthesis Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Voice Prosthesis Device Market, highlighting leading vendors and their innovative profiles. These include Andreas Fahl Medizintechnik - Vertrieb GmbH, Coloplast A/S, Demant A/S, E. Benson Hood Laboratories, Inc., Griffin Laboratories, Inc., InHealth Technologies, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Luminaud Inc., Nu-Vois, Orbisana Healthcare, Smiths Group PLC, Sonova Holding AG, Teleflex Incorporated, and Ultravoice Limited.

Market Segmentation & Coverage

This research report categorizes the Voice Prosthesis Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Valve, market is studied across Blom-Singer Valve, Groningen Valve, and Provox Valve.
  • Based on Device, market is studied across Indwelling Voice Prosthesis Devices and Non-Dwelling Voice Prosthesis Devices.
  • Based on End User, market is studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of laryngeal and throat cancer globally
      • 5.1.1.2. Increasing patient awareness on the availability of these devices for treatment
      • 5.1.1.3. Availability of favorable reimbursement policies and presence of large target patient population
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively expensive device due to high cost of manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing government funding on healthcare
      • 5.1.3.2. Extensive research and development to customize the device to improve patient compliance and reduced effort to speak
    • 5.1.4. Challenges
      • 5.1.4.1. Associated complications on the device usage and short lifespan
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Voice Prosthesis Device Market, by Valve

  • 6.1. Introduction
  • 6.2. Blom-Singer Valve
  • 6.3. Groningen Valve
  • 6.4. Provox Valve

7. Voice Prosthesis Device Market, by Device

  • 7.1. Introduction
  • 7.2. Indwelling Voice Prosthesis Devices
  • 7.3. Non-Dwelling Voice Prosthesis Devices

8. Voice Prosthesis Device Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Center
  • 8.3. Hospital

9. Americas Voice Prosthesis Device Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Voice Prosthesis Device Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Voice Prosthesis Device Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Andreas Fahl Medizintechnik - Vertrieb GmbH
  • 2. Coloplast A/S
  • 3. Demant A/S
  • 4. E. Benson Hood Laboratories, Inc.
  • 5. Griffin Laboratories, Inc.
  • 6. InHealth Technologies
  • 7. Johnson & Johnson Services, Inc.
  • 8. KARL STORZ SE & Co. KG
  • 9. Luminaud Inc.
  • 10. Nu-Vois
  • 11. Orbisana Healthcare
  • 12. Smiths Group PLC
  • 13. Sonova Holding AG
  • 14. Teleflex Incorporated
  • 15. Ultravoice Limited
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦